Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study

BACKGROUND: Septic shock is a leading cause of death in critical patients. In patients with gram-negative septic shock, hemoperfusion with polymyxin B aims to remove endotoxins from plasma. We analyzed the clinical and biological response to hemoperfusion in patients with septic shock and acute kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Navas, Ana, Ferrer, Ricard, Martínez, Maria Luisa, Gomà, Gemma, Gili, Gisela, Masip, Jordi, Suárez, David, Artigas, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286296/
https://www.ncbi.nlm.nih.gov/pubmed/30535929
http://dx.doi.org/10.1186/s13613-018-0465-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286296/
https://www.ncbi.nlm.nih.gov/pubmed/30535929
http://dx.doi.org/10.1186/s13613-018-0465-8

Ejemplares similares